Outlook Therapeutics, Inc. Common Stock — Chart, Price & News (NASDAQ:OTLK) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization 140.2 M
Employee 17
Founded 2010
CEO N/A
Website www.outlooktherapeutics.com
Headquarter Delaware, United States
FIGI BBG00469JRJ5
Industry Biotechnology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

Price to earnings ratio

-0.59

Price to sales ratio

32.63

News

Outlook Therapeutics: Potential Catalysts Offering An Arbitrage Opportunity (NASDAQ:OTLK)

Oncobiologics, Inc. (OTLK) Reports Q2 Loss, Lags Revenue Estimates

Outlook Therapeutics Files FDA Resolution Request After Rejection For Vision Loss Drug - Outlook Therapeu

Outlook Therapeutics secures $18.4M note, extends debt maturity

Outlook Therapeutics discusses FDA meeting on bevacizumab drug

Oncobiologics, Inc. (OTLK) Reports Q1 Loss, Misses Revenue Estimates

OTLK Stock Crashes 67% in a Week: Here's What You Need to Know

Outlook Therapeutics stock price target lowered to $0.50 at H.C. Wainwright

Dow Jumps Over 300 Points On First Trading Day Of 2026: Fear & Greed Index Remains In 'Neutral Zone - Micron Technology (NASDAQ:MU), NVIDIA (NASDAQ:NVDA)

The Narrowing Pathway for Biotech Securities Fraud Claims: Lessons from Outlook Therapeutics - TipRanks.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.66%

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Aimei Health Technology (NASDAQ:AFJK), Astera Labs (NASDAQ:ALAB)